ReviewInternational journal of molecular sciences2021

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective.

Cristina Hernando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.